P124 neo-ALTTO (neoadjuvant lapatinib and/or trastuzumab treatment optimisation) study [BIG 1-06/SOLTI/EGF106903]: a phase III translational study for Her2-overexpressing early breast cancer (BC)

✍ Scribed by J. Baselga; M.J. Piccart-Gebhart; R.D. Gelber; S. di Cosimo; G. Viale; M. Koehler; F. Rojo

• Book ID: 114316037
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 45 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(07)70184-4